Western Standard LLC purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 72,900 shares of the medical device company’s stock, valued at approximately $5,228,000. Cooper Companies accounts for approximately 1.8% of Western Standard LLC’s portfolio, making the stock its 16th biggest holding.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Cooper Companies by 48.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock valued at $1,890,000 after purchasing an additional 7,363 shares in the last quarter. First Trust Advisors LP grew its position in shares of Cooper Companies by 115.8% in the second quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock valued at $9,702,000 after purchasing an additional 73,165 shares during the period. Cresset Asset Management LLC purchased a new stake in shares of Cooper Companies during the second quarter worth about $291,000. Cerity Partners LLC increased its stake in shares of Cooper Companies by 4.4% during the second quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock worth $1,272,000 after purchasing an additional 757 shares in the last quarter. Finally, Daiwa Securities Group Inc. increased its stake in shares of Cooper Companies by 2.8% during the second quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock worth $2,551,000 after purchasing an additional 973 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on COO shares. Needham & Company LLC decreased their price target on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. The Goldman Sachs Group set a $61.00 price objective on Cooper Companies in a research note on Wednesday, May 27th. Piper Sandler set a $86.00 price objective on Cooper Companies and gave the stock an “overweight” rating in a research note on Monday, June 1st. Citigroup restated a “neutral” rating and issued a $80.00 target price (up from $76.00) on shares of Cooper Companies in a research report on Thursday, August 13th. Finally, Robert W. Baird lowered their price target on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research note on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $81.64.
Cooper Companies Price Performance
Shares of NASDAQ COO opened at $76.73 on Thursday. The firm has a 50-day simple moving average of $71.59 and a 200-day simple moving average of $71.16. The stock has a market capitalization of $14.96 billion, a price-to-earnings ratio of 65.03, a price-to-earnings-growth ratio of 1.98 and a beta of 0.83. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83.
Cooper Companies (NASDAQ:COO – Get Free Report) last posted its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. During the same period in the previous year, the business posted $0.96 earnings per share. Cooper Companies’s quarterly revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.
About Cooper Companies
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Further Reading
- Five stocks we like better than Cooper Companies
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
